back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-01-20 11:57 Tx date 2021-01-14 |
$LXRP
Lexaria Bioscience Corp. |
Reese, Albert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
917 | ||
| Filed 2021-01-12 18:04 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Baxter, Nicholas W.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$48,000
+5,000 vol $9.60 each |
155,000 | |
| Filed 2021-01-12 18:03 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Baxter, Nicholas W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+11,000 vol |
341,000 | |
| Filed 2021-01-12 17:38 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
$70,003
+6,667 vol $10.50 each |
6,667 | |
| Filed 2021-01-12 17:36 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$237,996
+23,333 vol $10.20 each |
723,333 | |
| Filed 2021-01-12 17:34 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+215,912 vol |
6,693,256 | |
| Filed 2021-01-12 17:33 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+273,543 vol |
7,399,847 | |
| Filed 2021-01-12 16:05 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Quigley, Brian
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$31,996
+3,333 vol $9.60 each |
103,333 | |
| Filed 2021-01-12 15:57 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
McKechnie, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$48,000
+5,000 vol $9.60 each |
155,000 | |
| Filed 2021-01-12 15:56 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
McKechnie, William Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+13,191 vol |
408,929 | |
| Filed 2021-01-12 15:42 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Spissinger, Allan Horst
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$208,003
+21,667 vol $9.60 each |
671,667 | |
| Filed 2021-01-12 15:40 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Docherty, John Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$127,996
+13,333 vol $9.60 each |
1,291,666 | |
| Filed 2021-01-12 15:38 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Docherty, John Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$258,495
+18,333 vol $14.10 each |
1,278,333 | |
| Filed 2021-01-12 15:35 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Docherty, John Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$33,000
+10,000 vol $3.30 each |
1,260,000 | |
| Filed 2021-01-12 15:31 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Docherty, John Martin
5 - Senior Officer of Issuer
Holder: Docherty Management Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+54,075 vol |
1,676,325 | |
| Filed 2021-01-12 15:14 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Spissinger, Allan Horst
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$208,003
+21,667 vol $9.60 each |
||
| Filed 2021-01-12 15:10 Tx date 2021-01-11 |
$LXRP
Lexaria Bioscience Corp. |
Spissinger, Allan Horst
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+3,972 vol |
123,138 | |
| Filed 2020-11-10 16:16 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,799
+25,500 vol $0.1882 each |
6,477,344 | |
| Filed 2020-11-10 16:15 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,199
+6,000 vol $0.1999 each |
6,451,844 | |
| Filed 2020-11-10 16:14 Tx date 2020-11-10 |
$LXRP
Lexaria Bioscience Corp. |
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+10,000 vol $0.195 each |
6,445,844 |